FDA to Host Public Hearing on Cannabis Friday

This Friday, May 31, the FDA will host a public hearing aimed at gathering scientific data and information about the safety, manufacturing, product quality, marketing, labeling and sale of cannabis-containing products and cannabis-derived compounds. The agency’s objective is to clarify a workable regulatory framework for the products since the cultivation and production of hemp was legalized in the 2018 Farm Bill.

A docket for public comment, FDA-2019-N-1482, will be available until July 2.


Selected tickers: Tilray (NASDAQ:TLRY), Canopy Growth (NYSE:CGC), Aurora Cannabis (NYSE:ACB), Cronos Group (NASDAQ:CRON), New Age Beverages (NASDAQ:NBEV)

Leave a Reply

Your email address will not be published. Required fields are marked *